| 0 |
NEUROTROPHIC KERATOPATHY |
1 |
0.0185 |
| 1 |
CORNEAL DEFECT |
1 |
0.0076 |
| 2 |
OCULAR SURFACE DISEASE |
1 |
0.0036 |
| 3 |
CANDIDA TEST POSITIVE |
1 |
0.0024 |
| 4 |
KERATITIS |
6 |
0.0020 |
| 5 |
OCULAR TOXICITY |
2 |
0.0018 |
| 6 |
BLOOD ALKALINE PHOSPHATASE ABNORMAL |
1 |
0.0011 |
| 7 |
INVESTIGATION ABNORMAL |
1 |
0.0007 |
| 8 |
CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY |
1 |
0.0007 |
| 9 |
PULMONARY SEPSIS |
1 |
0.0007 |
| 10 |
ASPARTATE AMINOTRANSFERASE ABNORMAL |
1 |
0.0007 |
| 11 |
SMALL INTESTINAL HAEMORRHAGE |
1 |
0.0005 |
| 12 |
ALANINE AMINOTRANSFERASE ABNORMAL |
1 |
0.0005 |
| 13 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
2 |
0.0004 |
| 14 |
ULCERATIVE KERATITIS |
1 |
0.0004 |
| 15 |
LUNG CANCER METASTATIC |
1 |
0.0003 |
| 16 |
PRODUCT CONTAMINATION |
1 |
0.0003 |
| 17 |
PNEUMONIA FUNGAL |
1 |
0.0003 |
| 18 |
METASTATIC NEOPLASM |
1 |
0.0002 |
| 19 |
EYE OPERATION |
1 |
0.0002 |
| 20 |
INFUSION SITE EXTRAVASATION |
1 |
0.0002 |
| 21 |
PRODUCT PREPARATION ISSUE |
1 |
0.0002 |
| 22 |
HYPERTRANSAMINASAEMIA |
1 |
0.0001 |
| 23 |
DUODENAL ULCER |
1 |
0.0001 |
| 24 |
PNEUMONITIS |
3 |
0.0001 |
| 25 |
PNEUMONIA BACTERIAL |
1 |
0.0001 |
| 26 |
AGRANULOCYTOSIS |
2 |
0.0001 |
| 27 |
INTERSTITIAL LUNG DISEASE |
4 |
0.0001 |
| 28 |
NEUROPATHY PERIPHERAL |
7 |
0.0001 |
| 29 |
PULMONARY ARTERIAL HYPERTENSION |
1 |
0.0001 |
| 30 |
MUSCLE TIGHTNESS |
1 |
0.0001 |
| 31 |
GENERALISED TONIC-CLONIC SEIZURE |
1 |
0.0001 |
| 32 |
HAEMORRHOIDS |
1 |
0.0001 |
| 33 |
PRODUCT PREPARATION ERROR |
1 |
0.0000 |
| 34 |
LIVER FUNCTION TEST INCREASED |
1 |
0.0000 |
| 35 |
DISEASE PROGRESSION |
5 |
0.0000 |
| 36 |
PANCREATIC CARCINOMA |
1 |
0.0000 |
| 37 |
VISION BLURRED |
4 |
0.0000 |
| 38 |
MYELOSUPPRESSION |
1 |
0.0000 |
| 39 |
DYSPNOEA EXERTIONAL |
1 |
0.0000 |
| 40 |
LUNG NEOPLASM MALIGNANT |
1 |
0.0000 |
| 41 |
SEPTIC SHOCK |
1 |
0.0000 |
| 42 |
PRODUCT STORAGE ERROR |
2 |
0.0000 |
| 43 |
LIVER DISORDER |
1 |
0.0000 |
| 44 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 45 |
RENAL DISORDER |
1 |
0.0000 |
| 46 |
PULMONARY EMBOLISM |
2 |
0.0000 |
| 47 |
DRY EYE |
1 |
0.0000 |
| 48 |
THERAPY CESSATION |
1 |
0.0000 |
| 49 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 50 |
FEBRILE NEUTROPENIA |
1 |
0.0000 |
| 51 |
INJECTION SITE REACTION |
1 |
0.0000 |
| 52 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
0.0000 |
| 53 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 54 |
PNEUMONIA |
4 |
0.0000 |
| 55 |
DEVICE ISSUE |
1 |
0.0000 |
| 56 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 57 |
PLATELET COUNT DECREASED |
1 |
0.0000 |
| 58 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 59 |
OFF LABEL USE |
8 |
0.0000 |
| 60 |
SEPSIS |
1 |
0.0000 |
| 61 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 62 |
CHILLS |
1 |
0.0000 |
| 63 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 64 |
NEUTROPENIA |
1 |
0.0000 |
| 65 |
PYREXIA |
2 |
0.0000 |
| 66 |
COVID-19 |
1 |
0.0000 |
| 67 |
ERYTHEMA |
1 |
0.0000 |
| 68 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 69 |
DEATH |
3 |
0.0000 |
| 70 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 71 |
FATIGUE |
2 |
0.0000 |
| 72 |
VOMITING |
1 |
0.0000 |
| 73 |
DYSPNOEA |
1 |
0.0000 |
| 74 |
PAIN |
1 |
0.0000 |
| 75 |
HEADACHE |
1 |
0.0000 |
| 76 |
NAUSEA |
1 |
0.0000 |
| 77 |
DRUG INEFFECTIVE |
1 |
0.0000 |